ICICI Lombard reported FY2026 PAT growth of 10.5% to ₹27.72 billion and proposed a final dividend of ₹7.00 per share.
The company achieved strong H2 growth of 15.7% in Gross Direct Premium Income, outperforming industry growth of 11.2%.
Retail Health business grew 51.1% for FY2026, significantly outpacing industry growth of 19.9% in the same period.
Combined Ratio stood at 103.4% on 1/n basis for FY2026, with solvency ratio at 2.67x as of March 31, 2026.